EMD Serono to provide reduced-cost fertility services through TrumpRx IVF initiative
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 16 2025
0mins
Source: SeekingAlpha
Agreement with Trump Administration: EMD Serono has reached an agreement with the Trump administration to offer in vitro fertilization (IVF) drugs at a significant discount through the TrumpRx program, allowing women to save up to 84% on certain medications used in IVF treatments.
New Manufacturing and Benefits: The company will start manufacturing IVF drugs in the U.S. to avoid tariffs and plans to submit Pergoveris for expedited FDA review. Additionally, CVS Health will support the program by providing services for those with insurance coverage for these medications.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
